Vitality Biopharma focuses on the development of cannabinoids for the treatment of neurological and inflammatory disorders, such as inflammatory bowel disease and multiple sclerosis. Its products in pipeline include Cannabosides - VITA-100 for gastrointestinal disorders, including inflammatory bowel disease and irritable bowel syndrome; Cannabosides - VITA-210 for muscle spasticity in multiple sclerosis and rare white matter disorders; and Cannabosides for epilepsy, schizophrenia, substance abuse and Huntington's disease.
|HQ||Los Angeles, US||Map|
Net income (FY, 2019)
EBIT (FY, 2019)
Market capitalization (8-Oct-2018)
When was Vitality Biopharma founded?
Vitality Biopharma was founded in 2012.
Who are Vitality Biopharma key executives?
Vitality Biopharma's key executives are Robert Brooke, Avtar Dhillon and Richard McKilligan.
How many employees does Vitality Biopharma have?
Vitality Biopharma has 8 employees.
What is Vitality Biopharma revenue?
Latest Vitality Biopharma annual revenue is $258.3 k.
What is Vitality Biopharma revenue per employee?
Latest Vitality Biopharma revenue per employee is $32.3 k.
Who are Vitality Biopharma competitors?
Competitors of Vitality Biopharma include Opiant Pharmaceuticals, IntelGenx and Mylan.
Where is Vitality Biopharma headquarters?
Vitality Biopharma headquarters is located at 1901 Avenue of the Stars 2nd Floor, Los Angeles.
Where are Vitality Biopharma offices?
Vitality Biopharma has an office in Los Angeles.
How many offices does Vitality Biopharma have?
Vitality Biopharma has 1 office.
Receive alerts for 300+ data fields across thousands of companies